139 related articles for article (PubMed ID: 8208127)
1. Evaluation of pyrazole and ethanol induced S9 fraction in bacterial mutagenicity testing.
Burke DA; Wedd DJ; Herriott D; Bayliss MK; Spalding DJ; Wilcox P
Mutagenesis; 1994 Jan; 9(1):23-9. PubMed ID: 8208127
[TBL] [Abstract][Full Text] [Related]
2. Mutagenicity of N-nitrosodiethylamine in the Ames test with S. typhimurium TA1535 is due to volatile metabolites and is not dependent on cytochrome P4502E1 induction.
Westphal GA; Bünger J; Schulz TG; Müller MM; Hallier E
Arch Toxicol; 2000 Dec; 74(10):638-41. PubMed ID: 11201672
[TBL] [Abstract][Full Text] [Related]
3. S9 induction by the combined treatment with cyclohexanol and albendazole.
Escobar-Garcia D; Camacho-Carranza R; Pérez I; Dorado V; Arriaga-Alba M; Espinosa-Aguirre JJ
Mutagenesis; 2001 Nov; 16(6):523-8. PubMed ID: 11682644
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the CYP isozyme profile induced by cyclohexanol.
Espinosa-Aguirre JJ; Rubio J; López I; Nosti R; Asteinza J
Mutagenesis; 1997 May; 12(3):159-62. PubMed ID: 9175641
[TBL] [Abstract][Full Text] [Related]
5. Modulation of rat liver cytochrome P450 by protein restriction assessed by biochemical and bacterial mutagenicity methods [corrected].
Cancino-Badías L; Reyes RE; Nosti R; Pérez I; Dorado V; Caballero S; Soria A; Camacho-Carranza R; Escobar D; Espinosa-Aguirre JJ
Mutagenesis; 2003 Jan; 18(1):95-100. PubMed ID: 12473742
[TBL] [Abstract][Full Text] [Related]
6. Use of human liver S9 in the Ames test: assay of three procarcinogens using human S9 derived from multiple donors.
Hakura A; Suzuki S; Sawada S; Sugihara T; Hori Y; Uchida K; Kerns WD; Sagami F; Motooka S; Satoh T
Regul Toxicol Pharmacol; 2003 Feb; 37(1):20-7. PubMed ID: 12662906
[TBL] [Abstract][Full Text] [Related]
7. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
[TBL] [Abstract][Full Text] [Related]
8. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y
Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
[TBL] [Abstract][Full Text] [Related]
9. A demonstration of the in vitro bacterial mutagenicity of procarbazine, using the microtitre fluctuation test and large concentrations of S9 fraction.
Gatehouse DG; Paes DJ
Carcinogenesis; 1983; 4(3):347-52. PubMed ID: 6339100
[TBL] [Abstract][Full Text] [Related]
10. Advantage of the use of human liver S9 in the Ames test.
Hakura A; Suzuki S; Satoh T
Mutat Res; 1999 Jan; 438(1):29-36. PubMed ID: 9858674
[TBL] [Abstract][Full Text] [Related]
11. Comparative activation of 3,3'-dichlorobenzidine and related benzidines to mutagens in the Salmonella typhimurium assay by hepatic S9 and microsomes from rats pretreated with different inducers of cytochrome P-450.
Iba MM
Mutat Res; 1987 Oct; 182(5):231-41. PubMed ID: 3309638
[TBL] [Abstract][Full Text] [Related]
12. The spectrum of enzymes involved in activation of 2-aminoanthracene varies with the metabolic system applied.
Veres Z; Török G; Tóth E; Vereczkey L; Jemnitz K
Mutat Res; 2005 Sep; 586(1):18-27. PubMed ID: 16006184
[TBL] [Abstract][Full Text] [Related]
13. Mutagenicity of cytochrome P450 2E1 substrates in the Ames test with the metabolic competent S. typhimurium strain YG7108pin3ERb5.
Emmert B; Bünger J; Keuch K; Müller M; Emmert S; Hallier E; Westphal GA
Toxicology; 2006 Nov; 228(1):66-76. PubMed ID: 16978761
[TBL] [Abstract][Full Text] [Related]
14. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test.
Yoshikawa K; Nohmi T; Miyata R; Ishidate M; Ozawa N; Isobe M; Watabe T; Kada T; Kawachi T
Mutat Res; 1982 Oct; 96(2-3):167-86. PubMed ID: 6755239
[TBL] [Abstract][Full Text] [Related]
15. Mutagenicity of nitrosamines in methyltransferase-deficient strains of Salmonella typhimurium coexpressing human cytochrome P450 2E1 and reductase.
Cooper MT; Porter TD
Mutat Res; 2000 Nov; 454(1-2):45-52. PubMed ID: 11035158
[TBL] [Abstract][Full Text] [Related]
16. The evaluation of methapyrilene for bacterial mutation with metabolic activation by Aroclor-induced, methapyrilene-induced and noninduced rat-liver S9.
Oberly TJ; Scheuring JC; Richardson KA; Richardson FC; Garriott ML
Mutat Res; 1993 Apr; 299(2):77-84. PubMed ID: 7680426
[TBL] [Abstract][Full Text] [Related]
17. Participation of rat liver cytochrome P450 2E1 in the activation of N-nitrosodimethylamine and N-nitrosodiethylamine to products genotoxic in an acetyltransferase-overexpressing Salmonella typhimurium strain (NM2009).
Yamazaki H; Oda Y; Funae Y; Imaoka S; Inui Y; Guengerich FP; Shimada T
Carcinogenesis; 1992 Jun; 13(6):979-85. PubMed ID: 1600620
[TBL] [Abstract][Full Text] [Related]
18. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests.
Gatehouse D; Wedd DJ
Carcinogenesis; 1984 Mar; 5(3):391-7. PubMed ID: 6368032
[TBL] [Abstract][Full Text] [Related]
19. N-benzylimidazole for preparation of S9 fraction with multi-induction of metabolizing enzymes in short-term genotoxicity assays.
Mori Y; Koide A; Fuwa K; Kobayashi Y
Mutagenesis; 2001 Nov; 16(6):479-86. PubMed ID: 11682638
[TBL] [Abstract][Full Text] [Related]
20. Induction of microsomal enzymes in liver of rats treated with cyclohexanol.
Espinosa-Aguirre JJ; Rubio J; Cassani M; Nosti R; Caballero S; González I; Martínez G
Mutat Res; 1996 Jun; 368(2):103-7. PubMed ID: 8684399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
